Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
PROCEPT BioRobotics's Total Liabilities for the quarter that ended in Jun. 2026 was MXN2,430 Mil.
PROCEPT BioRobotics's quarterly Total Liabilities
declined
from Dec. 2025 (MXN2,560.61 Mil) to Mar. 2026 (MXN2,513.67 Mil) and
declined
from Mar. 2026 (MXN2,513.67 Mil) to Jun. 2026 (MXN2,430.33 Mil).
PROCEPT BioRobotics's annual Total Liabilities
increased
from Dec. 2023 (MXN2,104.21 Mil) to Dec. 2024 (MXN2,748.72 Mil) but then
declined
from Dec. 2024 (MXN2,748.72 Mil) to Dec. 2025 (MXN2,560.61 Mil).
PROCEPT BioRobotics Total Liabilities Related Terms
PROCEPT BioRobotics Total Liabilities Historical Data
* Premium members only.
The historical data trend for PROCEPT BioRobotics's Total Liabilities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.
PROCEPT BioRobotics's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Total Liabilities of MXN2,430 Mil mean?
PROCEPT BioRobotics (MEX:PRCT) has a Total Liabilities of MXN2,430 Mil as of Jun. 2026. The total amount of liabilities as recorded on a company's balance sheet. View historical data for PROCEPT BioRobotics and its competitors.
Is PROCEPT BioRobotics' Total Liabilities too high?
PROCEPT BioRobotics' current Total Liabilities is MXN2,430 Mil. Overall, PROCEPT BioRobotics has a GF Score™ of 44/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does PROCEPT BioRobotics' Total Liabilities compare to INMD and LMRI?
PROCEPT BioRobotics' Total Liabilities of MXN2,430 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Devices & Instruments company?
A good Total Liabilities depends on the Medical Devices & Instruments industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for PROCEPT BioRobotics and its competitors. PROCEPT BioRobotics's current Total Liabilities is MXN2,430 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PROCEPT BioRobotics stock overvalued right now?
Based on GuruFocus' analysis, PROCEPT BioRobotics (MEX:PRCT) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN1,386.73, compared to a current price of MXN357.00 — trading 74.3% below its estimated fair value. The current Total Liabilities is MXN2,430 Mil. PROCEPT BioRobotics' overall GF Score™ is 44/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For PROCEPT BioRobotics (MEX:PRCT), the current Total Liabilities is MXN2,430 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PROCEPT BioRobotics (MEX:PRCT) Overvalued in 2026?
Based on GuruFocus' analysis, PROCEPT BioRobotics stock appears to be undervalued.
The current stock price of MXN357.00 is trading 74.3% below its estimated GF Value™ of MXN1,386.73.
GuruFocus considers PROCEPT BioRobotics to be Significantly Undervalued.
Key valuation signals for MEX:PRCT:
Total Liabilities: MXN2,430 Mil
GF Value™: MXN1,386.73 vs. price of MXN357.00 (74.3% below fair value)
No single metric tells the full story. See the MEX:PRCT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.
44GF Score
Get the complete analysis for MEX:PRCT
Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:PRCT has been successfully added to your 
